Current Opinion in Pulmonary Medicine

Article	Citations
The persistent problem of persistent air-leaks: approach to management	76
Bronchoscopic treatment of early-stage peripheral lung cancer	43
Home monitoring in asthma: towards digital twins	30
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	29
The role of PET in the management of sarcoidosis	28
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	27
The evolving role of radiological imaging in cystic fibrosis	26
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	22
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	21
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	20
Digital outcome measures in pulmonary clinical trials	20
Improving care in lung cancer surgery: a review of quality measures and evolving standards	20
Bronchoscopic diagnosis of peripheral lung lesions	18
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	18
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	18
Implementation of digital home monitoring and management of respiratory disease	18
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	18
Group 2 pulmonary hypertension: from diagnosis to treatment	17
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	17
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	17
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	16
Editorial introductions	15
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	15
The future of clinical trials in idiopathic pulmonary fibrosis	14
Editorial introductions	14

Asthma in pregnancy: a review of recent literature	14
Lung transplant referral considerations for individuals with cystic fibrosis	14
Considerations and clinical management of infections in sarcoidosis	14
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	13
Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity	13
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	12
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	12
Casting light on the many facets of sarcoidosis	12
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	12
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	12
Progress for all: addressing disparities in sarcoidosis	12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Cystic fibrosis liver disease in the post-modulator era	12
Home monitoring of coronavirus disease 2019 patients in different phases of disease	11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	11
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	11
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	11
Acute rejection post lung transplant	11
What causes cough in pulmonary fibrosis, and how should we treat it?	10
Patterns of progression in non-IPF fibrotic interstitial lung disease	10
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	10
Digital inhalers for asthma management	10
Tobacco treatment in the setting of lung cancer screening	10
Imaging in peripheral bronchoscopy	10
Novel insights in fibrotic pulmonary sarcoidosis	9
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	9
Effectiveness and safety of coronavirus disease 2019 vaccines	9
Editorial: Are we ready for prime time?	9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	9
Multidisciplinary care in nonmalignant central airway obstruction	9
Exhaled breath analysis in interstitial lung disease	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	9
Infection control in cystic fibrosis: evolving perspectives and challenges	8
Telerehabilitation in pulmonary diseases	8
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	8
Adenotonsillectomy: the good, the bad and the unknown	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	8
The changing landscape of infections in the lung transplant recipient	8
Editorial: ‘What is your occupation?’: historical snippets	8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	8
Epigenetics and aging: relevance for sleep medicine	8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
The association of preexisting severe asthma with COVID-19 outcomes	8
Telehealth and virtual health monitoring in cystic fibrosis	7
Advancements in airway stents: a comprehensive update	7

Right ventricular assessment in pulmonary hypertension	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	7
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	7
Ergonomics in bronchoscopy	7
Military deployment-related respiratory problems: an update	6
Editorial introductions	6
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	6
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	6
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	6
Approach to the hospitalized patient with pulmonary arterial hypertension	6
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	6
Methamphetamine-associated pulmonary arterial hypertension	6
Prader–Willi syndrome: an update	6
Editorial introductions	6
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	6
Updates in the diagnosis and management of chronic thromboembolic disease	6
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	6
COVID-19 outcomes in people with cystic fibrosis	6
Long-term safety, durability of response, cessation and switching of biologics	6
Editorial introductions	6
Drug-resistant tuberculosis: advances in diagnosis and management	5
Rapid eye movement predominant obstructive sleep apnoea: prognostic relevance and clinical approach	5
Bronchoscopic lung volume reduction in emphysema: a review	5
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	5
Bronchoscopic interventions for chronic bronchitis	5
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	5
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano	5
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	5
Recent advances predict a bright future for nebulizers	5
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	5
Pulmonary alveolar proteinosis – current and future therapeutical strategies	5
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	5
Editorial introductions	5
Bacteriophages for bronchiectasis: treatment of the future?	5
Artificial intelligence for the optimal management of community-acquired pneumonia	5
Health inequities in the modulator era	5
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	5
Editorial introductions	5
Interstitial lung disease following coronavirus disease 2019	5
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	5
Environmental and occupational exposures in interstitial lung disease	4
Lung infections due to emerging fungal pathogens	4
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	4
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	4
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	4
Editorial introductions	4
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”	4
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	4
Risk stratification of pulmonary embolism	4
Anesthetic considerations in interventional pulmonology	4
Indwelling pleural catheters for benign pleural effusions: a concise review	4
Recent developments in occupational asthma	4
What is new in mediastinal staging?	4
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	4
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	4
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	4
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation	4
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine	4
Editorial: The role of ageing in pulmonary disease	4
Role of biomarkers in lung nodule evaluation	4
Bedside to bench and back again-translational research in interventional pulmonology	3
COVID-19: vaccines, efficacy and effects on variants	3
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	3
Whole lung lavage: considerations from the anesthesiology perspective	3
Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges	3
SMART - is it practical in the United States?	3
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	3
Glymphatic MRI techniques in sleep and neurodegenerative diseases	3
Sex differences in sleep and sleep-disordered breathing	3
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	3
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	3
Editorial introduction	3
Editorial introductions	3
Vitamin D deficiency in chronic obstructive pulmonary disease	3
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	3
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic	3
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	3
Management of complicated parapneumonic effusions	3
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	3

The controversy over daylight saving time: evidence for and against	3
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	3
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	3
Leveraging AI technology in sarcoidosis	3
Pulmonary adverse events following immune checkpoint inhibitors	3
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	3